Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
26.58
+2.68 (11.21%)
At close: Aug 13, 2025, 4:00 PM
26.60
+0.02 (0.08%)
After-hours: Aug 13, 2025, 7:55 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $3.36 billion as of August 13, 2025. Its market cap has decreased by -29.59% in one year.

Market Cap
3.36B
Enterprise Value
3.45B
1-Year Change
-29.59%
Ranking
Category
Stock Price
$26.58

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $3.36B, an increase of 385.73%. That is a compound annual growth rate of 22.58%.

History

DateMarket Cap% Change
Aug 13, 20253.36B-15.43%
Dec 31, 20243.97B-44.04%
Dec 29, 20237.09B24.06%
Dec 30, 20225.72B24.22%
Dec 31, 20214.60B6.25%
Dec 31, 20204.33B121.45%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 574.04B
Johnson & Johnson 416.11B
AbbVie 350.91B
UnitedHealth Group 236.90B
AstraZeneca 232.33B
Novartis AG 230.64B
Abbott Laboratories 228.03B
Novo Nordisk 223.00B
Market Cap Rankings